Trailer Magazine


DHL investments boost healthcare supply chain

  • Posted on Thursday 29th, August 2019.

Australia’s life sciences and healthcare industry is set to become a key growth sector for DHL Global Forwarding in the years to follow.

DHL Global Forwarding has boosted its logistics capabilities including the establishment of three main facilities in Australia that adhere to the European Union’s Good Distribution Practice (GDP) guidelines for life sciences and healthcare supply chains.

At the inaugural DHL Global Forwarding Life Sciences and Healthcare Conference in Sydney, DHL representatives and customers discussed the future of the sector and how digitalisation and technology, such as big data analytics and Internet of Things (IoT), are transforming supply chains to improve visibility, traceability and cost-efficiency with global healthcare expenditures forecasted to reach $14.84 trillion by 2020.

“Longer life expectancies, prevalence of chronic diseases, and a growing middle class has led to an increase in global demand for healthcare products and services,” said DHL Global Forwarding CEO – North Asia/South Pacific and President / Representative Director of DHL Global Forwarding Japan, Charles Kaufmann.

“Among the sector’s brightest growth spots are new frontier discoveries that demand extremely sensitive and intelligent logistics handling.

“It is critical that industry players embrace smarter logistics to overcome the significant risks inherent in moving delicate substances and equipment around the world,” he said.

DHL Global Forwarding has a global network of facilities, and a complementary suite of life sciences and healthcare shipping solutions, designed to support Australian pharmaceutical businesses exporting to other markets. Two of its GDP facilities are also part of DHL Global Forwarding’s global network of air freight stations that meet International Air Transport Association’s (IATA) CEIV Pharma Standard. Integrating technology that allows real-time visibility and active monitoring, the DHL Air Thermonet and DHL Ocean Thermonet temperature-controlled freight solutions meet global industry standards in shipping products ranging from over-the-counter pharmaceutical drugs to medical equipment.

Recognising the potential of the industry, newly-appointed country manager for DHL Global Forwarding Australia, George Lawson, expects its life sciences and healthcare portfolio to be an important growth pillar for the business.

“Technological advancements and the support of a fully traceable supply chain are making Australia’s pharmaceutical products more affordable and accessible to patients everywhere,” said Lawson.

“With our team of sector experts I am confident that the growth of our life science and healthcare business will secure our market-leading position in Australia even as we tackle escalating volatility in global trade,” he said.

In other news, DHL Supply Chain launched a dedicated distribution centre in Truganina, Victoria, to support its operations with the world’s largest toymaker, Mattel.

© Copyright Prime Creative Media. All rights reserved.

Find us on Google+